LY3954068

LY3954068 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3954068, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease [Phase 1]